Long-Term Response Analysis of Transfusion Independence in Erythropoiesis Stimulating Agent-Naive Patients with Very Low-, Low-, or Intermediate-Risk Myelodysplastic Syndromes Treated with Luspatercept Vs Epoetin Alfa in the COMMANDS Trial
Year: 2024
Type: conference-abstract
Source: Blood
Institutions: The University of Texas MD Anderson Cancer Center, University of Florence, Yale Cancer Center, Yale University, Moffitt Cancer Center, Bristol-Myers Squibb (United States), Vall d'Hebron Hospital Universitari, Hôpital Saint-Louis, Université Paris Diderot, Monash University, University Hospital Leipzig
Language: English
Subfield: Hematology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4405043345
